Jessica provides guidance on patent prosecution for the biopharma industry. Her expertise is in biotechnology, pharmaceuticals, cell therapy, and molecular biology. 

Before joining the firm, Jessica had a decade of experience in life sciences research. She served as a postdoctoral fellow at the National Institutes of Health, where she studied the biophysical properties of dopamine neurons and evaluated various Parkinson’s disease treatments to identify optimal therapies.

Thought Leadership

  • First Author, “In vivo patch-clamp recordings reveal distinct subthreshold signatures and threshold dynamics of midbrain dopamine neurons,” Nature Communications, December 2020
  • Co-Author, “Ventral tegmental area astrocytes orchestrate avoidance and approach behavior,” Nature Communications, March 2019
  • Co-Author, “Cocaine selectively reorganizes excitatory inputs to substantia nigra pars compacta dopamine neurons,” Journal of Neuroscience, January 2018
  • Co-Author, “A layer-specific corticofugal input to the mouse superior colliculus,” Cerebral Cortex, August 2018
     

Honors & Awards

  • The University of Texas at San Antonio, “The President’s Distinguished Achievement Award – Innovation and Impact”, 2019
  • The University of Texas at San Antonio, “Presidential Distinguished Research Fellowship”, 2016
     

Previous Experience

  • Postdoctoral fellow, National Institutes of Health, 2021-2024